Denali Advisors LLC United Therapeutics Corp Transaction History

Denali Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$179.86 - $214.88 $35,972 - $42,976	-200 Closed	0 $0
Q2 2021 Aug 20, 2021	BUY	$170.47 - $211.93 $17,047 - $21,193	100 Added 100.0%	200 $36,000
Q1 2021 Apr 26, 2021	SELL	$153.94 - $174.85 $523,396 - $594,490	-3,400 Reduced 97.14%	100 $17,000
Q4 2020 Jan 20, 2021	SELL	$101.87 - $151.79 $81,496 - $121,432	-800 Reduced 18.6%	3,500 $531,000
Q3 2020 Oct 16, 2020	SELL	$99.9 - $121.13 $239,760 - $290,712	-2,400 Reduced 35.82%	4,300 $434,000
Q2 2020 Jul 23, 2020	BUY	$92.74 - $125.82 $621,358 - $842,994	6,700 New	6,700 $811,000
Q4 2019 Jan 30, 2020	SELL	$78.31 - $95.34 $751,776 - $915,264	-9,600 Closed	0 $0
Q3 2019 Oct 09, 2019	SELL	$74.85 - $85.99 $5.76 Million - $6.61 Million	-76,900 Reduced 88.9%	9,600 $766,000
Q2 2019 Jul 08, 2019	BUY	$76.06 - $120.81 $1.59 Million - $2.52 Million	20,900 Added 31.86%	86,500 $6.75 Million
Q1 2019 Apr 12, 2019	SELL	$107.15 - $126.84 $578,610 - $684,936	-5,400 Reduced 7.61%	65,600 $7.7 Million
Q1 2019 Apr 09, 2019	SELL	$107.15 - $126.84 $2.36 Million - $2.79 Million	-22,000 Reduced 23.66%	71,000 $8.33 Million
Q4 2018 Jan 15, 2019	BUY	$101.4 - $128.73 $9.43 Million - $12 Million	93,000 New	93,000 $10.1 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.